164 related articles for article (PubMed ID: 7521568)
1. Inhibitory effect of DS-4574, a peptidoleukotriene antagonist with mast cell stabilizing action, on compound 48/80-induced gastric mucosal lesions in rats.
Tabuchi Y; Kawarabayashi K; Furuhama K
Agents Actions; 1994 Mar; 41(1-2):21-4. PubMed ID: 7521568
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of DS-4574 on gastric mucosal injury induced by acidified ethanol in rats.
Tabuchi Y; Kawarabayashi K; Komada T; Furuhama K
Eur J Pharmacol; 1993 Nov; 250(1):197-9. PubMed ID: 7907021
[TBL] [Abstract][Full Text] [Related]
3. Effect of DS-4574, a novel peptidoleukotriene antagonist with mast cell stabilizing action, on acute gastric lesions and gastric secretion in rats.
Tabuchi Y; Kurebayashi Y
Jpn J Pharmacol; 1992 Dec; 60(4):335-40. PubMed ID: 1287268
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of DS-4574, a mast cell stabilizer with peptidoleukotriene receptor antagonism, on gastric acid secretion in rats.
Tabuchi Y; Furuhama K
Eur J Pharmacol; 1994 Apr; 255(1-3):229-34. PubMed ID: 8026547
[TBL] [Abstract][Full Text] [Related]
5. Role of endogenous serotonin and histamine in the pathogenesis of gastric mucosal lesions in unanaesthetised rats with a single treatment of compound 48/80, a mast cell degranulator.
Ohta Y; Kobayashi T; Ishiguro I
Pharmacol Res; 1999 Apr; 39(4):261-7. PubMed ID: 10208755
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of compound 48/80-induced gastric lesions in rats.
Takeuchi K; Ohtsuki H; Okabe S
Dig Dis Sci; 1986 Apr; 31(4):392-400. PubMed ID: 3956335
[TBL] [Abstract][Full Text] [Related]
7. Antisecretory effect of DS-4574, a mast cell stabilizer with peptidoleukotriene antagonism, on gastric acid secretion in the pig.
Yamashika Y; Tabuchi Y; Kokue E
Agents Actions; 1994 Mar; 41(1-2):17-20. PubMed ID: 8079817
[TBL] [Abstract][Full Text] [Related]
8. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions.
Shin HY; Kim JS; An NH; Park RK; Kim HM
Life Sci; 2004 Apr; 74(23):2877-87. PubMed ID: 15050425
[TBL] [Abstract][Full Text] [Related]
9. Enigma of disodium cromoglycate action on mast cells.
Krüger PG; Bloom GD
Int Arch Allergy Appl Immunol; 1979; 60(1):110-4. PubMed ID: 88418
[TBL] [Abstract][Full Text] [Related]
10. Histological evaluation of mast cells in rat gastric mucosal lesions induced by compound 48/80.
Arisawa T; Nakazawa S; Asai J; Tsukamoto Y
Digestion; 1989; 43(1-2):87-97. PubMed ID: 2806759
[TBL] [Abstract][Full Text] [Related]
11. Effect of antianaphylactic agents on substance-P induced histamine release from rat peritoneal mast cells.
Hachisuka H; Nomura H; Sakamoto F; Mori O; Okubo K; Sasai Y
Arch Dermatol Res; 1988; 280(3):158-62. PubMed ID: 2454082
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral vitamin E administration on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator.
Ohta Y; Kobayashi T; Imai Y; Inui K; Yoshino J; Nakazawa S
Biol Pharm Bull; 2006 Apr; 29(4):675-83. PubMed ID: 16595898
[TBL] [Abstract][Full Text] [Related]
13. Actions and cross-reactivity of antiallergic agents and a calcium channel antagonist on rat peritoneal mast cells. Difference in the action mechanisms and cross-reactivity among the agents.
Tanizaki Y; Ohtani J; Kimura I
Agents Actions; 1992 Sep; 37(1-2):8-15. PubMed ID: 1280907
[TBL] [Abstract][Full Text] [Related]
14. Studies on antiulcer agents. II. Antiulcer properties of N-(1H-tetrazol-5-yl)-2-anilino-5-pyrimidinecarboxamides inhibiting release of histamine from passively sensitized rat peritoneal mast cells.
Terashima K; Tanimura T; Shimamura H; Kawase A; Uenishi K; Tanaka Y; Kimura I; Kamisaki T; Ishizuka Y; Sato M
Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):1042-4. PubMed ID: 7543824
[TBL] [Abstract][Full Text] [Related]
15. Effect of gefarnate on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator, in comparison with that of teprenone.
Ohta Y; Kobayashi T; Imai Y; Inui K; Yoshino J; Nakazawa S
Biol Pharm Bull; 2005 Aug; 28(8):1424-30. PubMed ID: 16079487
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of rat peritoneal mast cell exocytosis by frusemide: a study with different secretagogues.
Stenton GR; Lau HY
Inflamm Res; 1996 Oct; 45(10):508-12. PubMed ID: 8912016
[TBL] [Abstract][Full Text] [Related]
17. Enhancement by reproterol of the ability of disodium cromoglycate to stabilize rat mastocytes.
Eleno N; Gajate E; Macias J; Garay RP
Pulm Pharmacol Ther; 1999; 12(1):55-60. PubMed ID: 10208836
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of brain mast cells by compound 48/80, a histamine liberator, evokes renin and vasopressin release in dogs.
Matsumoto I; Inoue Y; Shimada T; Matsunaga T; Aikawa T
Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R689-98. PubMed ID: 18184767
[TBL] [Abstract][Full Text] [Related]
19. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
Nabe T; Yamamura H; Kohno S; Ohata K
Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
[TBL] [Abstract][Full Text] [Related]
20. A protective action of disodium cromoglycate against the contraction of guinea-pig ileum induced by various pharmacological stimulants.
Kazimierczak W; Gonzalez Alvarez R; Maśliński C
Agents Actions; 1980 Apr; 10(1 Pt 2):8-14. PubMed ID: 6155773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
